Cardinal Health (NYSE: CAH) details Q2 results and outlook

Rhea-AI Filing Summary

Cardinal Health, Inc. reported that it has released its financial results for the quarter ended December 31, 2025, via a news release furnished as Exhibit 99.1. These second-quarter results cover the company’s performance midway through its fiscal year.

The Chief Executive Officer and Chief Financial Officer are scheduled to host a webcast at 8:30 a.m. Eastern time on February 5, 2026 to discuss the quarterly results and the outlook for the fiscal year ending June 30, 2026. A slide presentation and an audio replay of the webcast will be available on the Investors page at ir.cardinalhealth.com.

0000721371false00007213712026-02-052026-02-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 5, 2026

Cardinal Health, Inc.

(Exact name of registrant as specified in its charter)

Ohio

1-11373

31-0958666

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

7000 Cardinal Place, Dublin, Ohio 43017

(614) 757-5000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common shares (without par value)			CAH			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   p

Item 2.02: Results of Operations and Financial Condition

On February 5, 2026, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended December 31, 2025. A copy of the news release is included as Exhibit 99.1 to this report.

Item 7.01: Regulation FD Disclosure

During a webcast scheduled to be held at 8:30 a.m. Eastern time on February 5, 2026, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended December 31, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.

Item 9.01: Financial Statements and Exhibits

(d) Exhibits

Exhibit Number			Exhibit Description
99.1			News release issued by the Company on February 5, 2026 announcing second-quarter results.

2

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cardinal Health, Inc.

(Registrant)

Date:

February 5, 2026

By:

/s/ AARON E. ALT

Aaron E. Alt

Chief Financial Officer

3

FAQ

What did Cardinal Health (CAH) announce in its latest 8-K?

Cardinal Health announced it has issued a news release with financial results for the quarter ended December 31, 2025. The company also scheduled a webcast to discuss these second-quarter results and its outlook for the fiscal year ending June 30, 2026.

Which period do Cardinal Health (CAH) second-quarter results cover?

The reported second-quarter results cover Cardinal Health’s quarter ended December 31, 2025. These results represent the company’s performance in the middle of its fiscal year, ahead of a webcast discussion and detailed investor materials made available online.

When is the Cardinal Health (CAH) webcast to discuss results and outlook?

The webcast is scheduled for 8:30 a.m. Eastern time on February 5, 2026. During this event, Cardinal Health’s CEO and CFO plan to review second-quarter results and discuss the outlook for the fiscal year ending June 30, 2026 with investors.

Who from Cardinal Health (CAH) will present on the results webcast?

Cardinal Health’s Chief Executive Officer and Chief Financial Officer will lead the webcast. They plan to discuss the company’s second-quarter financial results and provide commentary on expectations for the fiscal year ending June 30, 2026, based on recently reported performance.

Where can investors access Cardinal Health (CAH) earnings materials and replay?

Investors can find the slide presentation and audio replay of the webcast on Cardinal Health’s Investors page at ir.cardinalhealth.com. The site will host the second-quarter results materials and related commentary from company leadership following the scheduled webcast.

What exhibit did Cardinal Health (CAH) attach with its second-quarter update?

Cardinal Health attached Exhibit 99.1, a news release dated February 5, 2026, announcing its second-quarter results. This exhibit provides the formal earnings communication accompanying the 8-K that references the quarter ended December 31, 2025 and related investor events.